Journal
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
Volume 31, Issue 2, Pages 190-192Publisher
ESMON PUBLICIDAD S A, DEPT ALLERGY & CLIN IMMUNOL, CLIN UNIV NAVARRA
DOI: 10.18176/jiaci.0672
Keywords
Nemolizumab; Meta-analysis; Atopic dermatitis; Efficacy; Safety
Categories
Funding
- National Natural Science Foundation of China [81602785]
- Fujian Province Natural Science Foundation [2017J05128]
- Fujian Provincial Health Technology Project [2019-ZQN-47]
- Opening Foundation of Research Platform of Fujian University of Traditional Chinese Medicine [X2018018]